Renally impaired patients - Are they on the right dose? 04/03/2020 Author: Boehringer Ingelheim Related content 00:48 Are your T2D patients on the right DPP4i dose? 00:38 DPP4i - Proven efficacy with no dose reduction 00:27 DPP4i – What efficacy to expect? 00:54 Efficacy, Safety, Simplicity all in one DPP4i 01:22 JENTADUETO® dosing information 00:21 Restricting TRAJENTA® to only renally impaired patients Production date: March 2020
